loadpatents
name:-0.016788959503174
name:-0.0075840950012207
name:-0.0047621726989746
Glicksman; Marcie Patent Filings

Glicksman; Marcie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Glicksman; Marcie.The latest application filed is for "system and method for controlling csf flow and managing intracranial pressure".

Company Profile
7.18.22
  • Glicksman; Marcie - Salem MA
  • Glicksman; Marcie - Winchester MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
System and Method for Controlling CSF Flow and Managing Intracranial Pressure
App 20220105322 - Riccardi; Gianna N. ;   et al.
2022-04-07
Subarachnoid Fluid Management Method And System With Varying Rates
App 20220096743 - Riccardi; Gianna N. ;   et al.
2022-03-31
Subarachnoid Fluid Management Method And System
App 20220096744 - Riccardi; Gianna N. ;   et al.
2022-03-31
Compounds that enhance Atoh1 expression
Grant 11,160,808 - Edge , et al. November 2, 2
2021-11-02
Compounds that Enhance Atoh1 Expression
App 20200179394 - Edge; Albert ;   et al.
2020-06-11
Small molecule inhibitors of USP1 deubiquitinating enzyme activity
Grant 10,653,676 - D'Andrea , et al.
2020-05-19
Compounds that enhance Atoh1 expression
Grant 10,406,163 - Edge , et al. Sept
2019-09-10
Small Molecule Inhibitors Of Usp1 Deubiquitinating Enzyme Activity
App 20170202810 - D'Andrea; Alan D. ;   et al.
2017-07-20
Compounds That Enhance ATOH1 Expression
App 20170095481 - Edge; Albert ;   et al.
2017-04-06
Identification Of Compounds That Disperse Tdp-43 Inclusions
App 20170088515 - Wolozin; Benjamin ;   et al.
2017-03-30
Phosphatidylcholine transfer protein inhibitors
Grant 9,556,129 - Cohen , et al. January 31, 2
2017-01-31
Small molecule inhibitors of USP1 deubiquitinating enzyme activity
Grant 9,518,032 - D'Andrea , et al. December 13, 2
2016-12-13
Pyridazine derivatives as EAAT2 activators
Grant 9,447,075 - Cuny , et al. September 20, 2
2016-09-20
Compounds that enhance Atoh1 expression
Grant 9,433,610 - Edge , et al. September 6, 2
2016-09-06
Identification of compounds that disperse TDP-43 inclusions
Grant 9,359,363 - Wolozin , et al. June 7, 2
2016-06-07
Phosphatidylcholine Transfer Protein Inhibitors
App 20150336902 - Cohen; David ;   et al.
2015-11-26
Phosphatidylcholine transfer protein inhibitors
Grant 9,126,938 - Cohen , et al. September 8, 2
2015-09-08
Compounds that Enhance Atoh1 Expression
App 20150157607 - Edge; Albert ;   et al.
2015-06-11
Inhibiting Eph B-3 kinase
Grant 8,927,545 - Qiao , et al. January 6, 2
2015-01-06
Compounds that enhance Atoh1 expression
Grant 8,859,597 - Edge , et al. October 14, 2
2014-10-14
Pyridazine derivatives as EAAT2 Activators
App 20140303174 - Cuny; Gregory D. ;   et al.
2014-10-09
Small Molecule Inhibitors Of Usp1 Deubiquitinating Enzyme Activity
App 20130253005 - D'Andrea; Alan D. ;   et al.
2013-09-26
Beta-Carbolines as Inhibitors of Haspin and DYRK Kinases
App 20130231360 - Higgins; Jonathan ;   et al.
2013-09-05
Acridines As Inhibitors Of Haspin And DYRK Kinases
App 20130102627 - Higgins; Jonathan ;   et al.
2013-04-25
Compounds That Enhance Atoh1 Expression
App 20120328580 - Edge; Albert ;   et al.
2012-12-27
Phosphatidylcholine Transfer Protein Inhibitors
App 20120264756 - Cohen; David ;   et al.
2012-10-18
Inhibiting EPH B-3 Kinase
App 20120238597 - Qiao; Lixin ;   et al.
2012-09-20
Compositions and Methods for Inhibiting Tumor Growth
App 20120208204 - Baldwin; Amy ;   et al.
2012-08-16
Compounds that enhance Atoh1 expression
Grant 8,188,131 - Edge , et al. May 29, 2
2012-05-29
Compounds That Enhance Atoh1 Expression
App 20090232780 - Edge; Albert ;   et al.
2009-09-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed